Samuel Sánchez, ICREA Research Professor at the Institute for Bioengineering of Catalonia (IBEC), will lead the OrthoBots project, which focuses on the treatment of joint diseases using nanorobots. To carry out the project, Sánchez has been awarded an ERC Proof of Concept Grant, a prestigious grant from the European Research Council.
The Nanomotors International Conference was held in Barcelona from 2 to 5 June. The event, organised by the Institute of Bioengineering of Catalonia (IBEC) in collaboration with the ‘la Caixa’ Foundation, the Catalunya La Pedrera Foundation, and the European Research Council (ERC), brought together the most prominent international leaders in the field of nanomotors. For three days, they learned about the latest advances in biomedical applications and the collective behaviour of self-propelled nanomotors, from both experimental and theoretical perspectives.
The research, which was conducted on mice, demonstrates how these tiny nanomachines are propelled by urea present in urine and precisely target the tumour, attacking it with a radioisotope carried on their surface. Led by the IBEC and CIC biomaGUNE, the study opens the door to new, more efficient treatments for bladder cancer.
IBEC researcher Samuel Sánchez has been honored with the 2023 Constantes y Vitales Award in the “Young Talent in Biomedical Research” category for his work on designing self-propelled nanorobots capable of delivering drugs within the human body. This initiative, presented by LaSexta and AXA Foundation, aims to foster biomedical research in Spain and spotlight the contributions of its scientists.
The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in … Read more
Samuel Sánchez has successfully secured an “ERC Proof of Concept” grant, provided by the European Research Council (ERC), to explore the application of his nanorobots in the treatment of mucus-secreting tumors. This prestigious grant enables researchers to assess the feasibility and potential for knowledge transfer of their research projects.
Today marked the second edition of the BASF-ICIQ Innovation and Entrepreneurship Awards, which reward excellence in the field of chemistry. The biomedical company Nanobots Therapeutics S.L., led by Prof. Samuel … Read more
Research Professor Samuel Sánchez presented last March 3rd in Brussels the new generation of NanoBots and BioBots developed in his research group at Institute of Bioengineering of Catalonia (IBEC) in Barcelona. The presentation took place during the European Research Council (ERC) Seminars. The audience was composed of scientific personnel of ERC, as well as a general audience from the European Commission.
With the title “Nanobots to 3D BioBots as future tools in robotics and medicine” Professor Sánchez presented during his seminar, fundamental aspects of catalytically powered nanoparticles -also called nanobots-, their applications in environmental remediation and also in future smart nanomedicine.